Use of GtfB as a Diagnostic for Caries Activity
Use of GtfB as a Diagnostic for Caries Activity
批准号:
7482074
负责人:
John Linforth Daiss
金额:
$18.6万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2010-06-30
关键词:
AcidsAddressAdsorptionAntibodiesArea Under CurveBacteriaBiological AssayBiological MarkersChildChildhoodCleaved cellClinicalClinical TrialsCross-Sectional StudiesDataDentalDental EnamelDental OfficesDental cariesDentistsDentitionDetectionDevelopmentDiagnosticDiagnostic testsDietary SucroseDiseaseDisease ProgressionEarly InterventionEnergy-Generating ResourcesEnzymesEpidemicEpitopesFreezingFrequenciesFructoseGenerationsGlucansGlucoseGoalsHumanImmunoassayImmunoblottingImmunoglobulin AImmunoglobulin GInterventionLaboratoriesLesionLongitudinal StudiesLow incomeMeasurementMeasuresMethodsMicrobial BiofilmsMonoclonal AntibodiesMonosaccharidesMorbidity - disease rateOffice VisitsPathogenesisPathologicPatientsPerformancePilot ProjectsPopulationPopulations at RiskPredictive ValueProbabilityPublic HealthReceiver Operator CharacteristicsRecoveryReportingRiskRoleRunningRural PopulationSalivaSalivarySamplingSchoolsSiteSourceStreptococcus mutansSurgeonTestingTimeTooth structureTraumaUnited StatesValidationVariantWhite Spotsbaseclinical efficacycostdiagnostic accuracyearly childhoodglucosyltransferase Bglucosyltransferase Dglycosyltransferaseinstrumentpathogenpediatricianpreventprototyperepairedsuccesstooltooth surface
中文摘要
描述(由申请人提供):本申请的总体目标是创建一种简单,快速,廉价的诊断测试,可以在办公室就诊期间使用,在明显的龋齿病变出现之前检测龋齿活动,以便在牙列发生永久性损伤之前进行干预。本应用的具体目的是临床验证一种免疫测定法,测量GtfB作为基于唾液的标记物,用于早期儿童龋齿(ECC)流行人群的儿童龋齿活动。这种方法是基于对龋齿发病机制的深入了解。三种糖基转移酶(GtfB, GtfC和GtfD)由变形链球菌定殖在牙齿表面时分泌。这些酶将蔗糖分解成单糖,将葡萄糖聚合成可溶和不可溶的葡聚糖,形成紧密粘附的富含细菌的生物膜,这是龋齿的特征,而果糖则被用作能量来源并产生可溶解牙釉质的酸。Gtfs在疾病进展中的核心作用使它们成为活动性龋齿的可信标记。在最近的一项横断面临床试验中,Bowen实验室通过测量唾液中GtfB的水平来区分患有ECC的儿童和无疾病的儿童,诊断准确率约为80%。有了这样一个充满希望的开端,两个问题变得至关重要:1)GtfB免疫测定是否会成为一种有效的工具,用于前瞻性地识别龋齿活动性儿童;2)当该方法在办公室环境中可用时,该检测的临床性能可以优化的方法。这个应用程序解决了这些问题。Specific Aim 1的重点是一项100例患者的临床试验,以确定GtfB测量是否可以在出现临床可检测的龋齿病变之前识别患有龋齿疾病的儿童。临床无龋齿的24-60个月的儿童将每三个月检查一次白斑病变或明显空洞,为期一年。同时采集唾液样本并测量GtfB。临床问题将是:尚不清楚唾液GtfB值升高是否预示3、6或9个月后可检测到的龋齿病变的出现。具体目标2和3解决了额外的抗gtfb单克隆抗体和替代免疫分析格式的创建,因此我们最终可以制作基于唾液,快速,廉价,无仪器的早期龋齿诊断测试。公共卫生意义:使用GtfB作为龋活动的诊断。龋齿仍然是发病率和费用的主要来源。仅在美国,每年就花费480亿美元来修复这种完全可以预防的疾病的后果。儿童早期龋齿(ECC)是一种特别严重的形式,在贫困的城市和农村人口中很常见,形成了外科医生报告中所说的“无声的流行病”。减轻龋齿负担所需的工具之一是一种简单、廉价、可在办公室进行的诊断测试,它可以识别患有活动性龋齿的儿童,以便在他们的牙齿受到不可逆转的损害之前采取干预措施。诊断必须足够简单和快速,它可以在儿科或牙科办公室使用。第一个目标是验证唾液传播的,病原体衍生的标记物,即在这种纵向测试中提出的分析物。
英文摘要
DESCRIPTION (provided by applicant): The over-arching objective of this application is the creation of a simple, rapid, inexpensive diagnostic test that can be used during an office visit to detect caries activity before overt carious lesions are apparent so that interventions can be made before permanent damage to the dentition occurs. The specific objective of this application is the clinical validation of an immunoassay measuring GtfB as a saliva-based marker for caries activity in children from a population where Early Childhood Caries (ECC) is prevalent. This method is predicated on an intimate understanding of the pathogenesis of Dental caries. Three glycosyltransferases (GtfB, GtfC and GtfD) are secreted by S. mutans when it colonizes the tooth surface. These enzymes cleave dietary sucrose into its constituent monosaccharides, glucose which is polymerized into soluble and insoluble glucans that create the tightly adherent, bacteria-rich biofilm that characterizes caries, and fructose which is utilized as an energy source and yields enamel-dissolving acids. The central role of Gtfs in disease progression makes them plausible markers for active caries. In a recent cross-sectional clinical trial, the Bowen laboratory distinguished children with ECC from disease-free children with about 80% diagnostic accuracy by measuring the levels of GtfB in their saliva. With such a promising start, two issues become paramount: 1) whether the GtfB immunoassay will be an effective tool for identifying caries-active children prospectively; and 2) ways by which the clinical performance of the assay can be optimized while the method is made useable in an office setting. This application addresses exactly these questions. The focus of Specific Aim 1 is a 100 patient clinical trial to determine whether GtfB measurement can identify children who have the disease Dental caries before they have clinically detectable carious lesions. Clinically caries-free children 24-60 months old will be examined for white spot lesions or frank cavitation every three months for a year. Saliva samples will be taken at the same time and GtfB measured. The clinical question will be: It is not clear whether elevated salivary GtfB values predict the emergence of detectable carious lesions 3, 6 or 9 months later. Specific Aims 2 and 3 address the creation of additional anti-GtfB monoclonal antibodies and alternative immunoassay formats so we can ultimately make a saliva-based, rapid, inexpensive, instrument-free diagnostic test for incipient Dental caries. Public Health Significance: Use of GtfB as a Diagnostic for Caries Activity. Dental caries remains a major source of morbidity and expense. In the United States alone, $48 billion are spent each year repairing the consequences of this completely preventable disease. A particularly severe form, Early Childhood Caries (ECC) is common in impoverished urban and rural populations creating what the Report of the Surgeon General called a silent epidemic. Among the tools needed for reducing the burden of Dental caries is a simple, inexpensive, in-office, diagnostic test that can identify children with active caries so that interventions can be made before their teeth become irreversibly damaged. The diagnostic must be simple and rapid enough that it can be used in a pediatric or Dental office. The first goal is to validate a saliva-borne, pathogen-derived marker that is the proposed analyte in such a longitudinal test.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core 1: Osteoimmunology Core
-
批准号:10247794
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2017
-
负责人:John Linforth Daiss
-
依托单位:
Anti-Autolysin Passive Immunity for MRSA Osteomyelitis
-
批准号:7999014
-
项目类别:
-
资助金额:$32.62万
-
财政年份:2010
-
负责人:John Linforth Daiss
-
依托单位:
Coupled Gene Delivery and Protein Transduction for the Reduction of Atheroscleros
-
批准号:7612615
-
项目类别:
-
资助金额:$17.58万
-
财政年份:2009
-
负责人:John Linforth Daiss
-
依托单位:
Core 1: Osteoimmunology Core
-
批准号:9370635
-
项目类别:
-
资助金额:$29.87万
-
财政年份:--
-
负责人:John Linforth Daiss
-
依托单位:
海外基金